CLINICAL_TRIALS
trial_result
· 2012-07-26
Clinical Trial Update: Ulimorelin Study of Efficacy and Safety (ULISES 007) [Phase 3]
Summary
Phase 3 clinical trial update for ulimorelin in gastrointestinal motility disorders assessing efficacy and safety; study completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tranzyme, Inc. | Conditions: Gastrointestinal Dysmotility | Phase 3 | Status: COMPLETED